AGL40.15▲ 0.12 (0.00%)AIRLINK133.72▲ 4.41 (0.03%)BOP6.75▼ -0.05 (-0.01%)CNERGY4.46▼ -0.18 (-0.04%)DCL8.76▲ 0.13 (0.02%)DFML41.25▲ 0.3 (0.01%)DGKC84.68▼ -1.06 (-0.01%)FCCL32.59▼ -0.41 (-0.01%)FFBL67.8▲ 1.27 (0.02%)FFL11.24▼ -0.22 (-0.02%)HUBC109.2▼ -1.38 (-0.01%)HUMNL14.24▼ -0.39 (-0.03%)KEL5.24▲ 0 (0.00%)KOSM8.22▲ 0.11 (0.01%)MLCF39.37▼ -0.7 (-0.02%)NBP60.51▲ 0 (0.00%)OGDC195▼ -0.47 (0.00%)PAEL26.9▼ -0.2 (-0.01%)PIBTL7.49▼ -0.15 (-0.02%)PPL155.4▼ -0.42 (0.00%)PRL26.71▼ -0.66 (-0.02%)PTC18.35▼ -0.21 (-0.01%)SEARL84▼ -1.1 (-0.01%)TELE8.2▲ 0.3 (0.04%)TOMCL34.14▼ -0.74 (-0.02%)TPLP8.94▼ -0.28 (-0.03%)TREET16.7▼ -0.11 (-0.01%)TRG63.75▲ 0.89 (0.01%)UNITY27.43▼ -0.32 (-0.01%)WTL1.28▼ -0.02 (-0.02%)

European stocks slip on poor data

Share
Tweet
WhatsApp
Share on Linkedin
[tta_listen_btn]

London

Europe’s equity markets slipped Thursday on survey data indicating the region’s economy continued to be battered by coronavirus fallout, despite recent vaccine-driven optimism, dealers said. Investors weighed Covid-19 vaccine hopes against rising infections and uncertainty surrounding a post-Brexit trade deal, OPEC oil output and a US stimulus package. In late morning deals, London’s benchmark FTSE 100 index edged down 0.1 percent, having rallied the previous day after a sliding pound pushed up shares in multinationals.
Confirmation that Britain will next week start rolling out the Pfizer-BioNTech vaccine against Covid-19 has meanwhile led to traders booking profits following big share-price gains in recent weeks on expectations of mass inoculations before 2021.—AFP

Related Posts

Get Alerts